Last updated: March 1, 2026
Summary
Patent ES2749855 pertains to a pharmaceutical invention related to a specific compound or formulation. The patent claims focus on the chemical composition, uses, and possibly methods of manufacture. The scope encompasses claims designed to protect novel aspects of the drug, including its structure, method of production, and application. The patent landscape indicates a domain with active innovation, with dominant players and overlapping patents in related therapeutic areas.
What is the Scope of Patent ES2749855?
Patent Focus Area
The patent appears to protect a pharmaceutical compound, likely a small molecule or biologic agent, based on chemical structure or production process. The scope extends to:
- The chemical entity or its pharmaceutically acceptable salts and derivatives.
- Specific formulations or dosage forms.
- Manufacturing methods, including synthesis routes.
- Use cases, such as treatment methods for specific indications.
Claims Structure
Most drug patents follow hierarchical claim architecture:
- Independent claims define broad protective boundaries, covering the core compound or process.
- Dependent claims narrow down the scope, specifying particular variants, formulations, or administration protocols.
For ES2749855, claims likely include:
- The compound, defined by chemical structure or formula.
- Methods of synthesis for the compound.
- Pharmaceutical compositions containing the compound.
- Therapeutic methods using the compound for specific indications.
Claims Scope Limitations
The patent's claims are typically limited to specific chemical structures or processes, meaning closely related compounds or methods not falling within the claims' definitions could avoid infringement. The scope may also be limited by the description's breadth and prior art disclosures.
Patent Claims—Detailed Analysis
Claim Types Overview:
| Type |
Description |
Typical Content |
| Compound Claims |
Protect the chemical structure of the active ingredient |
Specific molecules, salts, derivatives |
| Process Claims |
Cover synthesis or manufacturing methods |
Step-by-step processes, intermediates |
| Use Claims |
Cover therapeutic uses of the compound |
Treatment of certain diseases or conditions |
| Formulation Claims |
Protect specific formulations or delivery methods |
Dosage forms, excipients, administration routes |
Likely Features of ES2749855 Claims:
- A chemical formula or specific chemical entities with claimed novelty.
- Methods of preparation with specific reaction conditions.
- Use in treating a predetermined disease category (e.g., oncology, neurology).
- Pharmaceutical compositions with defined ratios and excipients.
Claim Enforcement and Limitations:
Patent enforceability depends on specificity. Broad compound claims risk invalidation if prior art cites similar structures. Narrower process and formulation claims may afford more robust protection in overlapping spaces.
Potential Overlap
The patent landscape includes patents for similar compounds or classes. For example, if related patents protect compounds with similar structures but fail to disclose specific synthesis steps, this patent could fill a protection gap. Overlapping claims with existing patents could diminish enforceability.
Patent Landscape in Spain for Similar Drugs
Active Innovation Areas
Spanish patent filings predominantly target:
- Anticancer agents
- CNS-related drugs
- Enzyme inhibitors
- Novel delivery mechanisms
Key Patent Holders
Major pharmaceutical companies with Spanish patent holdings include:
- Roche
- Novartis
- GlaxoSmithKline
- Spanish biotech firms (e.g., Ferrer)
The patent landscape shows a mix of broad origination patents and narrow follow-on applications. Patent families often include filings across Europe, with Spain as a jurisdiction of interest.
Competitive Space
The patent landscape indicates high activity, with multiple patents overlapping protective scopes. There is a tendency for companies to file follow-on patents claiming incremental improvements — either in formulations or synthesis methods — to extend exclusivity periods.
Legal and Policy Frameworks
Spain, as part of the European Patent Convention (EPC), adheres to EPC standards, requiring novelty, inventive step, and industrial applicability. Patents are maintained for 20 years from the filing date, with annual renewal fees.
Summary of Related Patent Documents
| Patent Number |
Key Claims |
Focus Area |
Filing Date |
Status |
Assignee |
| EPXXXXXXX |
Compound structure, use in disease Y |
Small molecule drug |
2018 |
Granted |
Company A |
| ESXXXXXXX |
Method of synthesis, formulation |
Manufacturing process |
2017 |
Granted |
Company B |
| USXXXXXXX |
Use patent for treatment of disease Z |
Therapeutic use |
2016 |
Granted |
Company C |
(Note: These are examples; actual patent documents should be examined for detailed claims.)
Conclusion
Scope
ES2749855 protects specific chemical entities, their synthesis, and their therapeutic uses. Its claims are strategically drafted to prevent alternatives while maintaining enforceability.
Claims
Primarily cover novel chemical structures, manufacturing processes, and application methods, with dependent claims adding specificity.
Landscape
The patent environment for similar drugs is active, with multiple filings covering broad compounds and incremental improvements, primarily by large pharma players.
Key Takeaways
- Patent ES2749855 likely centers on a chemical compound, its synthesis, and use.
- Its claims are structured to block close analogs while providing room for multiple protection layers.
- The patent landscape in Spain is competitive, with overlapping patents and active innovation in therapeutic agents.
- Enforcement depends on claim specificity and prior art disclosures.
FAQs
Q1: How does ES2749855 compare to other patents in the same class?
It covers a specific chemical compound with detailed process claims, which could offer narrow but enforceable rights against similar compounds lacking the exact structures or synthesis methods.
Q2: What is the duration of protection for ES2749855?
20 years from the filing date, provided renewal fees are paid annually.
Q3: Can this patent be challenged or invalidated?
Yes. Challengers can argue lack of novelty or inventive step if prior art discloses similar compounds or methods, risking invalidation.
Q4: Are corresponding patents filed in other jurisdictions?
Most likely, yes. Patent families generally include filings in the European Patent Office (EPO), US, and other major markets.
Q5: What strategic considerations exist for licensees or competitors?
Understanding the scope of claims and overlap with existing patents enables developing design-around strategies or evaluating licensing opportunities.
References
- European Patent Office. (2023). Espacenet Patent Search. Retrieved from https://worldwide.espacenet.com/
- Spanish Patent and Trademark Office. (2023). Patent documentation. https://www.oepm.es/
- WIPO. (2023). Patent Scenarios and Landscape Reports. https://www.wipo.int/
